RxDoctor Payments Data

Virginia Nguyen, MD

Surgery · Norfolk, VANPI 1821470998

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (42.0%), travel and lodging and grants — rather than concentrated in one kind of arrangement. Medtronic accounts for 74.1% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2021 at $6,970 and has fallen 83.2% since, to $1,172 in 2025. Among surgery clinicians in VA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,927in general payments, 2019–2025

Across 147 payments — averaging $142.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$16K
  • W. L. Gore & Associates, Inc.$2K
  • Penumbra, Inc.$509
  • Inari Medical, Inc.$477
  • Abbott$455
  • Shockwave Medical, Inc$412
  • plus $1K from 10 others

What the payments were for

  • Grants$4,37521%
  • Travel & lodging$7,26235%
  • Food & beverage$8,79142%
  • Education$4992%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,927 in reported general payments places this provider in the 90th percentile of 675 surgery providers in Virginia.

See all surgery providers in Virginia

Medicare billing

Part B allowed, 2024
$90,023
Medicare patients
336
Services billed
630

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban23$18,900
ClopidogrelClopidogrel Bisulfate30$488
Cilostazol13$265
Oxycodone Hcl24$77

Paid to pharmacies, not to this prescriber.

Other surgery in Norfolk

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →